Antigen-presenting cells in the skin (APC (skin))

Antigen-presenting cells in the skin are a heterogeneous population mainly encompassing dendritic cells (especially Langerhans cells in the epidermis), dermal dendritic cells, monocytes, and macrophages. These cells constantly patrol the skin, sense antigens (microbial, environmental, tumor), process them, and present antigen fragments via MHC molecules to T cells to initiate and regulate adaptive immune responses. Their function and migration are tightly regulated by epidermal signals (e.g., cytokines from keratinocytes) that tailor immune outcomes for skin homeostasis, infection clearance, or tolerance. Skin APCs are central to vaccine response, immune surveillance in cancer, and the pathogenesis of inflammatory and autoimmune skin diseases. Their clinical relevance is predominantly in disease modulation and as targets of immunomodulating therapies administered via the skin. Note: "Antigen-presenting cells in the skin" should not be mapped as a canonical drug target but rather as a category; for drug development or mechanistic studies, resolution to specific APC subtypes or molecular mediators (e.g., CD207/Langerin, CD1a) is required.

Other names

Skin APCcutaneous APCepidermal antigen-presenting celldermal antigen-presenting cellLangerhans cell (specific subset)skin dendritic cellskin macrophage

Drugs/vaccines interact by: - Activating pattern-recognition receptors (e.g., TLRs) to stimulate APCs - Triggering migration and maturation of APCs to lymph nodes for T cell priming - Modulating local cytokine signaling (e.g., TNF-α, IL-1, TGF-β) - Inhibiting APC function to suppress immune response (immunosuppressive agents)